J.P. Morgan Notebook Day 1: No Big Deals, But Plenty Of Pipeline, Commercial Highlights

Daily round-up from the J.P. Morgan Healthcare Conference in San Francisco: There was no big M&A, but biopharma CEOs discussed deals they're pursuing. Also, Novartis's Zolgensma reimbursement insights, Sarepta's third DMD filing, Bristol's post-merger progress and more highlights.

Westin Hotel San Fransisco, CA
J.P. Morgan's Health Care Bash Kicked Off At The Westin St. Francis on 13 January. • Source: Shutterstock

The overarching theme so far at the J.P. Morgan Healthcare Conference this year is a big question: “Where are the deals?”

[Sidebar#SC141462]

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Market Access

More from Pink Sheet